In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations

E. De Vecchi, L. Nicola, F. Ossola, Lorenzo Drago

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Objectives: To compare the ability to select for resistance in Streptococcus pneumoniae of levofloxacin, moxifloxacin, ciprofloxacin and prulifloxacin. Methods: Twenty strains of S. pneumoniae susceptible to fluoroquinolones were used. The frequencies of spontaneous single-step mutations at plasma and epithelial lining fluid (ELF) peak and trough antibiotic concentrations were calculated. Multi-step selection of resistance was evaluated by performing 10 serial subcultures on agar plates containing a linear gradient from peak to trough antimicrobial concentrations, followed by 10 subcultures on antibiotic-free agar. Resistant strains selected after multi-step selection were characterized for DNA mutations by sequencing gyrA, gyrB, parC and parE genes. Results: Levofloxacin and moxifloxacin showed the lowest frequencies of mutations (median -11) at plasma peak and at ELF concentrations, while medians ranging from 10-8 to 10-6 were observed for ciprofloxacin and prulifloxacin. In a multi-step selection assay, ciprofloxacin and prulifloxacin selected for the highest number of resistant strains (19 and 31, respectively). No selection of resistance was observed for levofloxacin at ELF concentrations and for moxifloxacin at plasma and ELF concentrations. Mutations in parC, parE and gyrA genes were found in ciprofloxacin- and prulifloxacin-resistant strains, while only parC mutations were found for levofloxacin. Conclusions: Levofloxacin and moxifloxacin are characterized by a lower propensity to select in vitro for resistance in S. pneumoniae than ciprofloxacin and prulifloxacin, when tested at plasma and lung concentrations.

Original languageEnglish
Pages (from-to)721-727
Number of pages7
JournalJournal of Antimicrobial Chemotherapy
Volume63
Issue number4
DOIs
Publication statusPublished - 2009

Fingerprint

Levofloxacin
Fluoroquinolones
Ciprofloxacin
Streptococcus pneumoniae
Mutation
Agar
Anti-Bacterial Agents
Mutation Rate
DNA Sequence Analysis
Genes
In Vitro Techniques
prulifloxacin
Lung
moxifloxacin

Keywords

  • Ciprofloxacin
  • Frequency of mutation
  • Levofloxacin
  • Moxifloxacin
  • Prulifloxacin

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Pharmacology

Cite this

In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations. / De Vecchi, E.; Nicola, L.; Ossola, F.; Drago, Lorenzo.

In: Journal of Antimicrobial Chemotherapy, Vol. 63, No. 4, 2009, p. 721-727.

Research output: Contribution to journalArticle

@article{1fc1d993b2324e26b13a4f78a61c6614,
title = "In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations",
abstract = "Objectives: To compare the ability to select for resistance in Streptococcus pneumoniae of levofloxacin, moxifloxacin, ciprofloxacin and prulifloxacin. Methods: Twenty strains of S. pneumoniae susceptible to fluoroquinolones were used. The frequencies of spontaneous single-step mutations at plasma and epithelial lining fluid (ELF) peak and trough antibiotic concentrations were calculated. Multi-step selection of resistance was evaluated by performing 10 serial subcultures on agar plates containing a linear gradient from peak to trough antimicrobial concentrations, followed by 10 subcultures on antibiotic-free agar. Resistant strains selected after multi-step selection were characterized for DNA mutations by sequencing gyrA, gyrB, parC and parE genes. Results: Levofloxacin and moxifloxacin showed the lowest frequencies of mutations (median -11) at plasma peak and at ELF concentrations, while medians ranging from 10-8 to 10-6 were observed for ciprofloxacin and prulifloxacin. In a multi-step selection assay, ciprofloxacin and prulifloxacin selected for the highest number of resistant strains (19 and 31, respectively). No selection of resistance was observed for levofloxacin at ELF concentrations and for moxifloxacin at plasma and ELF concentrations. Mutations in parC, parE and gyrA genes were found in ciprofloxacin- and prulifloxacin-resistant strains, while only parC mutations were found for levofloxacin. Conclusions: Levofloxacin and moxifloxacin are characterized by a lower propensity to select in vitro for resistance in S. pneumoniae than ciprofloxacin and prulifloxacin, when tested at plasma and lung concentrations.",
keywords = "Ciprofloxacin, Frequency of mutation, Levofloxacin, Moxifloxacin, Prulifloxacin",
author = "{De Vecchi}, E. and L. Nicola and F. Ossola and Lorenzo Drago",
year = "2009",
doi = "10.1093/jac/dkp020",
language = "English",
volume = "63",
pages = "721--727",
journal = "Journal of Antimicrobial Chemotherapy",
issn = "0305-7453",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - In vitro selection of resistance in Streptococcus pneumoniae at in vivo fluoroquinolone concentrations

AU - De Vecchi, E.

AU - Nicola, L.

AU - Ossola, F.

AU - Drago, Lorenzo

PY - 2009

Y1 - 2009

N2 - Objectives: To compare the ability to select for resistance in Streptococcus pneumoniae of levofloxacin, moxifloxacin, ciprofloxacin and prulifloxacin. Methods: Twenty strains of S. pneumoniae susceptible to fluoroquinolones were used. The frequencies of spontaneous single-step mutations at plasma and epithelial lining fluid (ELF) peak and trough antibiotic concentrations were calculated. Multi-step selection of resistance was evaluated by performing 10 serial subcultures on agar plates containing a linear gradient from peak to trough antimicrobial concentrations, followed by 10 subcultures on antibiotic-free agar. Resistant strains selected after multi-step selection were characterized for DNA mutations by sequencing gyrA, gyrB, parC and parE genes. Results: Levofloxacin and moxifloxacin showed the lowest frequencies of mutations (median -11) at plasma peak and at ELF concentrations, while medians ranging from 10-8 to 10-6 were observed for ciprofloxacin and prulifloxacin. In a multi-step selection assay, ciprofloxacin and prulifloxacin selected for the highest number of resistant strains (19 and 31, respectively). No selection of resistance was observed for levofloxacin at ELF concentrations and for moxifloxacin at plasma and ELF concentrations. Mutations in parC, parE and gyrA genes were found in ciprofloxacin- and prulifloxacin-resistant strains, while only parC mutations were found for levofloxacin. Conclusions: Levofloxacin and moxifloxacin are characterized by a lower propensity to select in vitro for resistance in S. pneumoniae than ciprofloxacin and prulifloxacin, when tested at plasma and lung concentrations.

AB - Objectives: To compare the ability to select for resistance in Streptococcus pneumoniae of levofloxacin, moxifloxacin, ciprofloxacin and prulifloxacin. Methods: Twenty strains of S. pneumoniae susceptible to fluoroquinolones were used. The frequencies of spontaneous single-step mutations at plasma and epithelial lining fluid (ELF) peak and trough antibiotic concentrations were calculated. Multi-step selection of resistance was evaluated by performing 10 serial subcultures on agar plates containing a linear gradient from peak to trough antimicrobial concentrations, followed by 10 subcultures on antibiotic-free agar. Resistant strains selected after multi-step selection were characterized for DNA mutations by sequencing gyrA, gyrB, parC and parE genes. Results: Levofloxacin and moxifloxacin showed the lowest frequencies of mutations (median -11) at plasma peak and at ELF concentrations, while medians ranging from 10-8 to 10-6 were observed for ciprofloxacin and prulifloxacin. In a multi-step selection assay, ciprofloxacin and prulifloxacin selected for the highest number of resistant strains (19 and 31, respectively). No selection of resistance was observed for levofloxacin at ELF concentrations and for moxifloxacin at plasma and ELF concentrations. Mutations in parC, parE and gyrA genes were found in ciprofloxacin- and prulifloxacin-resistant strains, while only parC mutations were found for levofloxacin. Conclusions: Levofloxacin and moxifloxacin are characterized by a lower propensity to select in vitro for resistance in S. pneumoniae than ciprofloxacin and prulifloxacin, when tested at plasma and lung concentrations.

KW - Ciprofloxacin

KW - Frequency of mutation

KW - Levofloxacin

KW - Moxifloxacin

KW - Prulifloxacin

UR - http://www.scopus.com/inward/record.url?scp=62549154532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62549154532&partnerID=8YFLogxK

U2 - 10.1093/jac/dkp020

DO - 10.1093/jac/dkp020

M3 - Article

C2 - 19218275

AN - SCOPUS:62549154532

VL - 63

SP - 721

EP - 727

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

SN - 0305-7453

IS - 4

ER -